inlexisertib   Click here for help

GtoPdb Ligand ID: 13209

Synonyms: example 53 [US11530206]
Compound class: Synthetic organic
Comment: The chemical structure for inlexisertib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a serine/ threonine kinase inhibitor with antineoplastic potential. The structure is claimed in Deciphera Pharmaceuticals' patent US11530206 in which inhibition of ULK1 kinase is demonstrated [1]. We predicted that inlexisertib might be Deciphera's clinical lead ULK inhibitor DCC-3116, and this was confirmed at the first time disclosures session at the 2024 ACS spring meeting in New Orleans.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 84.8
Molecular weight 535.61
XLogP 1.14
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC1=CC(=CC=C1NC2=NC(=C(C=N2)C(F)(F)F)NCCCN3CCOCCC3=O)N4CCN(C)CC4
Isomeric SMILES CCC1=CC(=CC=C1NC2=NC=C(C(NCCCN3CCOCCC3=O)=N2)C(F)(F)F)N4CCN(C)CC4
InChI InChI=1S/C26H36F3N7O2/c1-3-19-17-20(35-12-10-34(2)11-13-35)5-6-22(19)32-25-31-18-21(26(27,28)29)24(33-25)30-8-4-9-36-14-16-38-15-7-23(36)37/h5-6,17-18H,3-4,7-16H2,1-2H3,(H2,30,31,32,33)
InChI Key CNBTYICEJGEABG-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel